The global custom antibody market is projected to reach $0.8 billion by 2028, at a CAGR of 10.4% during 2023-2028. The growth of custom antibody market is driven by increasing government funding investments for research and development activities, rise in therapeutics of antibodies, and growing demand for protein therapeutics.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the most promising, high-growth opportunities for the custom antibody market by service (antibody development, antigen preparation, immunization & hybridoma production, antibody characterization, antibody production & purification, and others), type (monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others), application (research and therapeutics), end use industry (pharmaceutical & biotechnological companies, academic & research institutes, and others), and region?
Q.2 Which segments will grow at a faster pace and why?
Q.3 What are the business risks and threats to the custom antibody market?
Q.4 What are some changing demands of customers in the custom antibody market?
Q.5 What are the new developments in the custom antibody market? Which companies are leading these developments?
Q.6 What strategic initiatives are being implemented by key players for business growth?
Q.7 What are some of the competitive products and processes in this custom antibody area and how big of a threat do they pose for loss of market share via product substitution?
Q.8 What M&A activity has occurred in the last 5 years in this custom antibody market?
Market Segmentation:
Based on service, the custom antibody market is segmented into antibody development, antigen preparation, immunization & hybridoma production, antibody characterization, antibody production & purification, and others. The antibody development segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing incidence of chronic diseases and rising investment in R&D activities by the market players.
North America is expected to remain the largest segment over the forecast period due to increasing concern over catalog antibodies, growing number of cancer research and genomics research program, and presence of major companies in the region.
Key Players in the custom antibody market are Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Abcam, Cell Signaling Technology, Bio-Rad Laboratories, GenScript, and Rockland Immunochemicals.
Request Sample Pages by clicking on https://www.lucintel.com/custom-antibody-market.aspx
The report helps stakeholders understand the pulse of the market and provides them with information on key drivers, restraints, challenges, and opportunities for market growth. It would also help to understand the competitors better and gain more insights to improve their position in the business.
To read more about this market please click on https://www.lucintel.com/custom-antibody-market.aspx
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Roy AlmaguerLucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. 972.636.5056
Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email:Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/
